AptaBio Therapeutics Inc. (KOSDAQ:293780)
South Korea · Delayed Price · Currency is KRW 7,730.00
+80.00 (1.05%)
Nov 20, 2025, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 213.58 billion as of November 19, 2025. Its market cap has increased by 2.96% in one year.
Market Cap
213.58B
Enterprise Value
199.50B
Revenue
3.11B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,730.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 213.58B, a decrease of -49.54%. That is a compound annual growth rate of -10.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 213.58B | 24.73% |
| Dec 30, 2024 | 171.23B | -15.15% |
| Dec 28, 2023 | 201.80B | -15.02% |
| Dec 29, 2022 | 237.48B | -71.24% |
| Dec 30, 2021 | 825.71B | 46.50% |
| Dec 30, 2020 | 563.64B | 49.70% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 43.20T |
| ALTEOGEN | 29.31T |
| SK Biopharmaceuticals | 10.20T |
| ABL Bio | 9.70T |
| Yuhan | 9.35T |
| Peptron | 7.22T |
| HLB Co., Ltd. | 6.50T |